Thromb Haemost 1999; 81(03): 471-472
DOI: 10.1055/s-0037-1614503
Letters to the Editor
Schattauer GmbH

Interference with Oral Anticoagulant Treatment by Oestrogen – Influence of Oestrogen Administration Route

Frédéric Cotton
1   From the Departments of Clinical Pathology and of Université Libre de Bruxelles, Brussels, Belgium
,
Philippe Sorlin
1   From the Departments of Clinical Pathology and of Université Libre de Bruxelles, Brussels, Belgium
,
Bernard Corvilain
2   Departments of Endocrinology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
,
Jean-Marie Fockedey
1   From the Departments of Clinical Pathology and of Université Libre de Bruxelles, Brussels, Belgium
,
Paul Capel
1   From the Departments of Clinical Pathology and of Université Libre de Bruxelles, Brussels, Belgium
› Author Affiliations
Further Information

Publication History

Received23 July 1998

Accepted10 November 1998

Publication Date:
09 December 2017 (online)

 

 
  • References

  • 1 Kroon U-B, Silfverstolpe G, Tengborn L. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables. Thromb Haemost 1994; 71: 420-3.
  • 2 Scarabin P-Y, Plu-Bureau G, Bara L, Bonithonn-Kopp C, Guize L, Samama MM. Haemostatic variables and menopausal status: influence of hormone replacement therapy. Thromb Haemost 1993; 70: 584-7.
  • 3 Pacifici GM, Viani A, Rizzo G, Carrai M. Plasma protein binding of ethinyloestradiol: effect of disease and interaction with drugs. Int J Clin Pharmacol Ther Toxicol 1989; 27: 362-5.
  • 4 De Lignieres B, Basdevant A, Thomas G, Thalabard J-C, Mercier-Bodard C, Conard J, Guyene T-T, Mairon N, Corvol P, Guy-Grand B, MauvaiS-Jarvis P, Sitruk-Ware R. Biological effects of estradiol-17β in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab 1986; 62: 536-41.
  • 5 De Teresa E, Vera A, Ortigosa J, Alonso Pulpon L, Puente Arus A, De Artaza M. Interaction between anticoagulants and contraceptives: an unsuspected finding. Br Med J 1979; 2: 1260-1.